Cargando…
Molecular characterisation of cutaneous melanoma: creating a framework for targeted and immune therapies
Large-scale genomic analyses of cutaneous melanoma have revealed insights into the aetiology and heterogeneity of this disease, as well as opportunities to further personalise treatment for patients with targeted and immune therapies. Herein, we review the proposed genomic classification of cutaneou...
Autores principales: | Rajkumar, Shivshankari, Watson, Ian R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947706/ https://www.ncbi.nlm.nih.gov/pubmed/27336610 http://dx.doi.org/10.1038/bjc.2016.195 |
Ejemplares similares
-
Targeting BRAF for patients with melanoma
por: Arkenau, H-T, et al.
Publicado: (2011) -
Single-cell analysis of tumors: Creating new value for molecular biomarker discovery of cancer stem cells and tumor-infiltrating immune cells
por: Radpour, Ramin, et al.
Publicado: (2018) -
New perspectives on molecular targeted therapy in ovarian clear cell carcinoma
por: Tan, D S P, et al.
Publicado: (2013) -
Beyond BRAF: where next for melanoma therapy?
por: Fedorenko, I V, et al.
Publicado: (2015) -
Targeted and immune therapies for hepatocellular carcinoma: Predictions for 2019 and beyond
por: Kudo, Masatoshi
Publicado: (2019)